Note 11 - Business Combinations, Dispositions and Other Strategic Investments (Details) - Disposal Groups, Including Discontinued Operations (USD $)	1 Months Ended	3 Months Ended
	Apr. 17, 2014	Sep. 30, 2014 Watson Product [Member]	Sep. 30, 2014 ECR Pharmaceuticals Divestiture [Member]	Jun. 20, 2014 ECR Pharmaceuticals Divestiture [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Consideration received		$ 16,800	$ 41,000	$ 41,000,000
Intangible assets disposed		(5,900)	(33,600)
Goodwill disposed		(1,100)	(10,400)
Other assets disposed		(800)	(1,200)
Assumed liabilities divested			5,100
Gain recognized	$ 9,000,000	$ 9,000	$ 900